Showcases Stock ranks Forex

Bausch Health Companies Inc (BHC)
5.84  0.25 (4.47%) 08-08 16:00
Open: 5.61 Pre. Close: 5.59
High: 5.89 Low: 5.58
Volume: 7,720,410 Market Cap: 2,124M
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 5.898 - 5.921 5.921 - 5.944
Low: 5.523 - 5.548 5.548 - 5.573
Close: 5.798 - 5.839 5.839 - 5.879
Stock Technical Analysis
Target: Six months: 8.53
One year: 10.91
Support: Support1: 4.00
Support2: 3.33
Resistance: Resistance1: 7.30
Resistance2: 9.34
Pivot: 6.85
Moving Averages: MA(5): 5.27
MA(20): 7.33
MA(100): 13.01
MA(250): 21.03
MACD: MACD(12,26): -0.99
Signal(12,26,9): -0.81
%K %D: %K(14,3): 28.40
%D(3): 23.64
RSI: RSI(14): 36.84
52-Week: High: 29.59
Low: 4
Change(%): -78.8
Average Vol(K): 3-Month: 7290
10-Days: 14849
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

[ BHC ] has closed above bottom band by 36.9%. Bollinger Bands are 71.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
Stock chart
Stock News
Mon, 08 Aug 2022
Drug, Biotech Stocks' Q2 Earnings on Aug 9: EXEL, BHC & More - Nasdaq

Thu, 04 Aug 2022
Bausch + Lomb Announces Second-Quarter 2022 Results - Yahoo Finance

Tue, 02 Aug 2022
Bausch Health Stock: A Seemingly Disastrous State Of Affairs (NYSE:BHC) - Seeking Alpha

Thu, 28 Jul 2022
Midday Movers: Meta Platforms, Bausch Health, Spirit Airlines and More By -

Thu, 28 Jul 2022
Why Shares of Bausch Health Companies Dropped 54.4% This Week - The Motley Fool

Thu, 28 Jul 2022
Is Bausch Health Companies Inc (BHC) Stock a Attractive Value? - InvestorsObserver

Financial Analysis
Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. (M) 361.48
Shares Float (M) 299.67
% Held by Insiders 2.99
% Held by Institutions 74.64
Shares Short (K) 16330
Shares Short Prior Month (K) 16240
Stock Financials
EPS -1.130
Book Value (p.s.) -0.600
Profit Margin -4.89
Operating Margin 19.72
Return on Assets (ttm) 3.5
Return on Equity (ttm)
Qtrly Rev. Growth -5.4
Gross Profit (p.s.) 16.709
Sales Per Share 23.044
EBITDA (p.s.) 8.687
Qtrly Earnings Growth
Operating Cash Flow (M) 920.00
Levered Free Cash Flow (M) 1550.00
Stock Valuation
PE Ratio -5.17
PEG Ratio 0.10
Price to Book value -9.73
Price to Sales 0.25
Price to Cash Flow 2.29
Stock Dividends
Dividend Yield 0.17
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android